Support JDRF Corporate Partners in Fall JDRF Sneaker Sales

Support JDRF Corporate Partners in Fall JDRF Sneaker Sales

Each year, Marshalls, Advanced Auto Parts and Republic Finance, our dedicated JDRF corporate partners hold JDRF Paper Sneaker Sales whose proceeds help JDRF fund type 1 diabetes (T1D) research. They also raise awareness of JDRF and the critical need for research to benefit people living with T1D among their employees and in the communities in which […]

JDRF 2015 Children’s Congress application site remains open

JDRF is pleased to announce that applications for JDRF 2015 Children’s Congress are currently being accepted. JDRF Children’s Congress, our highest profile advocacy event, is held every two years in the nation’s capital. Next year’s event will take place from July 13 to 15, 2015. It will include more than 150 children, ages 4 to […]

JDRF 2015 Children’s Congress

Calling all kids aged 4-17 with T1D.  The JDRF 2015 Children’s Congress application is now open!  Spend July 13-15, 2015 in Washington, D.C. making lifelong friends, educating Congress and getting to know our T1D role models.  Apply today and represent our Chapter!

CGM-Medicare Bill Introduced in House

JDRF Commends U.S. Representatives Reed, DeGette and Whitfield for Introducing Continuous Glucose Monitor (CGM) Coverage Legislation JDRF commends U.S. Representatives Tom Reed (R-NY), Diana DeGette (D-CO) and Ed Whitfield (R-KY) for introducing legislation, H.R. 5644, the ‘Medicare CGM Access Act of 2014,’ calling for continuous glucose monitor (CGM) coverage by Medicare. This legislation (which now […]

Volunteer Spotlight: Martin Gilmore

Volunteer Spotlight: Martin Gilmore

Martin Gilmore and his wife Susan were Co-Chairs of the Piedmont Triad Hope Gala in 2013. Martin Gilmore is a focused professional and dedicated father who is “in the game” until JDRF has accomplished its vision of creating a world without type 1 diabetes (T1D). Why JDRF? Martin’s daughter, Margaret, was diagnosed with T1D in 2007 […]

A New Switch Hitter for Type 1 Diabetes Discovered

Pancreatic cells are more adaptable and possess a greater potential for self-healing than previously assumed For decades, the prevailing wisdom was that beta cells could not regenerate and that their loss in type 1 diabetes (T1D) was irreversible—the reason why people with T1D require insulin injections for life. JDRF-funded research is helping rewrite the textbook […]

Boost JDRF research progress at Walgreens and Duane Reade

Get your flu shot at your community Walgreens or Duane Reade and JDRF will receive money for T1D research From September 1 to November 30, Walgreens will donate $1 to JDRF per flu shot to our supporters — up to a total of $100,000! Download and bring in this JDRF promotional flyer on your visit. […]

Research Teamwork is Key to Curing Type 1 Diabetes

JDRF takes center stage at Capitol Hill briefing on accelerating biomedical research progress Richard A. Insel, M.D., JDRF’s Chief Scientific Officer, joined other research leaders at a Congressional briefing on, “How the Research-by-Consortia Model Will Lead to Faster Cures” held recently in Washington D.C. The briefing brought together biomedical leaders from foundations, industry, government, and […]

JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial

Updated Sept. 18, 2014 JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate. The company plans to immediately initiate the first ever clinical evaluation of a stem […]